U.S. Entertainment Stock News

NYSE:GM
NYSE:GMAuto

General Motors Stock And 2 Auto Names After The Stellantis Earnings Shock

The latest Stellantis earnings update shows how quickly sentiment can swing when results and expectations do not line up. Net profit moved to €293 million in Q2 from a loss of €1.87 billion a year earlier, and adjusted operating income reached €773 million. However, the stock still fell as much as 8% on the day because the figure came in below the €914 million consensus. That kind of reaction can ripple across North American auto manufacturers. This article looks at 3 stocks exposed to that...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Should Walmart’s (WMT) Expanding Brand Partnerships and Ad Tools Shape Its AI-Driven Omni-Channel Story?

In recent weeks, a series of partner announcements has expanded Walmart’s assortment and ecosystem exposure, from Kate Farms’ High Protein Nutrition Shake rollout across more than 6,800 Walmart and CVS locations to Edible Garden’s fresh herb expansion in Mid-Atlantic stores and Final Boss Sour’s planned entry into Walmart’s shelves. At the same time, integration into tools like Shirofune’s Walmart Connect interface and a reported investor rotation toward defensive retailers underline how...
NYSE:HIMS
NYSE:HIMSHealthcare

Hims & Hers Health (HIMS) Faces FTC Lawsuit Over Health Data And Billing

The Federal Trade Commission, Utah, and Los Angeles County filed a lawsuit against Hims & Hers Health (NYSE:HIMS) alleging unauthorized sharing of sensitive health data and deceptive billing practices. The complaint focuses on how the company handled patient information on its telehealth platform and how subscriptions and cancellations were billed and processed. The action highlights potential regulatory and reputational risks for Hims & Hers Health that investors may weigh when assessing...
NYSE:NEM
NYSE:NEMMetals and Mining

3 U.S. Value Stocks To Watch As Higher Oil And Rates Stir Markets

The latest 1,000 point drop in the Dow after the Federal Reserve held interest rates steady has put value stocks back under the spotlight. With inflation still above target and U.S. oil prices near US$85 per barrel, many investors are taking a fresh look at large U.S. companies that already trade on lower price ratios and have some dividend history. This article focuses on three U.S. Large Cap Value Stocks from our screener that appear more directly exposed to the current rate and oil...
NYSE:AIR
NYSE:AIRAerospace & Defense

AAR (AIR) Is Up 6.1% After Robust Q4 Earnings And New Shelf Filing - Has The Bull Case Changed?

AAR Corp. recently reported fourth-quarter 2026 results showing sales of US$928 million and net income of US$50.7 million, alongside a completed US$107.54 million share repurchase program that retired 2,429,700 shares under its 2021 authorization. The company also filed an omnibus shelf registration covering multiple security types, giving it broad flexibility to raise capital after a year in which full-year earnings per share from continuing operations increased markedly. We’ll now examine...
NYSE:XPO
NYSE:XPOTransportation

XPO (XPO) Adds Former United Rentals CEO Michael Kneeland To Its Board

Michael Kneeland, former CEO and current non executive chairman of United Rentals, has joined the board of directors of NYSE:XPO. Kneeland brings leadership experience in industrial services, equipment rental and logistics related businesses. This appointment marks a recent change in XPO's board composition and governance structure. XPO operates in freight transportation and logistics, a sector that depends heavily on operational efficiency, capital discipline and consistent service...
NYSE:GRMN
NYSE:GRMNConsumer Durables

US Stock Market Today: S&P 500 Futures Edge Higher As Fed And Oil Risks Loom

The Morning Bull - US Market Morning Update Thursday, Jul, 30 2026 US market stock futures are pointing slightly higher this morning, with E-mini S&P 500 contracts up about 0.3%, as investors weigh interest rate risks and energy prices. The US 10 year Treasury yield is steady ahead of the Federal Reserve meeting, where markets see roughly a one in three chance of a rate hike now and about 80% odds in September. That reflects concern that Middle East related oil price moves could keep...
NYSE:RSG
NYSE:RSGCommercial Services

Is Republic Services (RSG) A Bargain Following Strike Authorization And Labor Charges?

Republic Services (RSG) is back in focus after workers represented by Teamsters Local 104 unanimously voted to authorize a strike and filed an unfair labor practice charge, raising fresh questions around labor relations and potential operational risk. See our latest analysis for Republic Services. Republic Services shares recently closed at US$218.91, with short term momentum reflected in a 1 day share price return of 1.05% and a 90 day share price return of 4.63%, while the 1 year total...
NasdaqGS:ATAT
NasdaqGS:ATATHospitality

Atour Lifestyle Holdings (ATAT) Draws Fresh Analyst Optimism, Is The Stock Still Undervalued?

Recent analyst reports on Atour Lifestyle Holdings (NasdaqGS:ATAT) have focused on upward revisions to earnings estimates and a Zacks Rank #1. This has drawn fresh attention to the stock within the leisure and recreation services sector. See our latest analysis for Atour Lifestyle Holdings. Atour Lifestyle Holdings has seen short term momentum pick up, with a 12.30% 7 day share price return and 9.31% 30 day share price return, although the share price is still down 11.39% year to date. The 3...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

Will QURE’s AMT-130 Regulatory Momentum Offset Mounting Losses And Share Dilution Risk?

In the past week, uniQure N.V. reported Q2 2026 results showing revenue of US$5.84 million alongside a much larger quarterly net loss of US$81.06 million, while also filing a US$12.83 million shelf registration for 350,000 ordinary shares tied to its employee share plan. At the same time, the company advanced its regulatory plans for AMT-130 in Huntington’s disease and highlighted promising early data in epilepsy and Fabry programs, framing a contrast between widening losses and progress in...
NYSE:TXT
NYSE:TXTAerospace & Defense

Textron (TXT) Beat Expectations, Is The Stock Still Cheap?

Textron (TXT) is back in focus after its latest update combined several key signals. The company reported second quarter results, reaffirmed full year 2026 earnings guidance, and confirmed completion of a planned share repurchase tranche. See our latest analysis for Textron. Textron's recent earnings beat, reiterated 2026 guidance and completion of its buyback tranche came as the share price fell 4.8% on the day and 10.7% over 90 days, while the 1 year total shareholder return of 9.8% points...
NasdaqGS:ULTA
NasdaqGS:ULTASpecialty Retail

Is Ulta Beauty (ULTA) Using Fashion Collaborations To Deepen Its Youth-Focused Brand Moat?

Pacsun and Ulta Beauty have already rolled out an exclusive Pacsun x Ulta Beauty capsule across stores and online, while Ulta has recently backed several category-expanding launches, including plusOne sexual wellness products, Peach & Lily’s “Zombie Cream,” and Ice Spice’s debut fragrance with Revlon. Together, these collaborations and exclusive launches reinforce Ulta Beauty’s role as a key platform where fashion, wellness, science-led skincare, and celebrity-driven products intersect for...
NasdaqGS:NOVT
NasdaqGS:NOVTElectronic

Novanta (NOVT) Completes Riverpoint Medical Deal To Expand Recurring Consumables Revenue

Novanta (NasdaqGS:NOVT) has completed its acquisition of Riverpoint Medical. The deal significantly increases Novanta's exposure to the medical consumables market. Management expects the transaction to approximately double recurring medical consumables revenue. Novanta focuses on precision photonics, vision and motion technologies used in medical and advanced industrial applications. With Riverpoint Medical now under its umbrella, the company gains a larger footprint in medical consumables,...
NYSE:OC
NYSE:OCBuilding

Did Owens Corning's (OC) New CFO and COO Roles Just Redefine Its Execution Playbook?

Owens Corning recently announced that Jonathan Collins will become Executive Vice President and Chief Financial Officer on August 10, 2026, succeeding Todd Fister, who moves into the newly defined role of President and Chief Operating Officer to oversee enterprise initiatives and operational execution. The appointment brings in a finance leader with experience integrating generative AI and managing complex transformations, while freeing Fister to concentrate on aligning operations and...
NasdaqGS:SSNC
NasdaqGS:SSNCProfessional Services

SS&C Technologies (SSNC) Is Up 16.8% After ESOP-Linked Share Shelf And Strong Q2 Earnings Results

In late July 2026, SS&C Technologies Holdings, Inc. filed a US$779 million shelf registration for 10,000,000 common shares tied to an ESOP-related offering, shortly after reporting second-quarter 2026 revenue of US$1,695.7 million and net income of US$234.8 million, both higher than the prior year. The earnings release also showed higher basic and diluted earnings per share from continuing operations for both the quarter and first half of 2026, pointing to improved profitability alongside...
NasdaqGM:ETON
NasdaqGM:ETONPharmaceuticals

Is Eton Pharmaceuticals (ETON) Quietly Reframing Its Orphan-Drug Strategy With KHINDIVI’s Label Expansion Bid?

Eton Pharmaceuticals has submitted a Prior Approval Supplement to the FDA seeking to extend KHINDIVI’s hydrocortisone oral solution label to younger pediatric patients with adrenocortical insufficiency, beyond its current approval for those aged five and older. This move, backed by bioequivalence data versus ALKINDI SPRINKLE, could broaden treatment options in a rare disease population where Eton estimates about 10,000 U.S. pediatric patients. With KHINDIVI already the only FDA-approved...
NYSE:PNR
NYSE:PNRMachinery

Pentair (PNR) Stock May Be A Bargain Following Fraud Probe Fallout

Pentair stock has fallen sharply this year, yet the company still screens as undervalued on several key checks, including an intrinsic value estimate that sits well above the current share price. With sentiment hit by legal investigations and weaker trading in parts of the business, investors are weighing whether the current discount fairly reflects the risks now in play. Year to date, Pentair shares are down 36.9%, which means current holders have taken a sizeable hit and new investors are...
NasdaqGS:FLEX
NasdaqGS:FLEXElectronic

Flex (FLEX) Following Record Results, Is The Pullback A Buying Opportunity?

Flex stock reacts to record quarter and raised 2027 outlook Flex (FLEX) is back in focus after reporting record first quarter fiscal 2027 earnings, lifting full year revenue guidance and confirming plans to separate its Cloud and Power Infrastructure business. See our latest analysis for Flex. The sharp share price pullback after earnings, including a 1-day share price return that declined 9.06% and a 30-day share price return that fell 36.43%, comes after very strong long term momentum, with...
NasdaqGS:STNE
NasdaqGS:STNEDiversified Financial

StoneCo (STNE) Could Be 33% Undervalued Following Its Cross Selling Growth Narrative

StoneCo (STNE) is back in focus after the stock fell 2.15%, lagging major indexes, as investors look ahead to the company’s August 13, 2026 earnings release. See our latest analysis for StoneCo. The recent 1-day share price return decline of 1.79% and 7-day decline of 3.52% extend a weaker short term trend for StoneCo. At the same time, the 1-year total shareholder return of 2.45% and 5-year total shareholder return decline of 76.58% point to mixed longer term outcomes around the current...
NasdaqCM:VRDN
NasdaqCM:VRDNBiotechs

How Positive Elegrobart REVEAL-1 Phase III Data Could Impact Viridian Therapeutics (VRDN) Investors

Viridian Therapeutics recently reported positive topline results from its Elegrobart REVEAL-1 phase III trial in Graves' ophthalmopathy and outlined plans to submit a Biologics License Application in early 2027. This progress, combined with the recent approval of Viridian’s LUMVOA and a pipeline that includes other emerging therapies for Graves’ ophthalmopathy, highlights the company’s growing role in this specialized autoimmune eye disease market. We’ll now examine how the positive...
NYSE:BSX
NYSE:BSXMedical Equipment

Low Volatility Stocks Investors Are Watching As Fed Rate Signals Turn Less Clear

Fed Chair Kevin Warsh’s move to dial back forward guidance has left markets more data driven and, at times, more jumpy. When rate clues are harder to read, many investors start to focus on stocks that have shown relatively low price swings and steadier profiles. That is where a low volatility screener can help filter the chaos. This article looks at three stocks from that list that appear positively exposed to the current policy uncertainty and recent volatility in Treasury yields, and...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Adobe (ADBE) Joins Open Source AI Cybersecurity Alliance As AI Security Effort Expands

Adobe, ticker NasdaqGS:ADBE, has joined a new coalition to launch the Open Source AI Cybersecurity Alliance. The alliance focuses on open source collaboration to improve cybersecurity for artificial intelligence systems. This company initiative has not been widely covered in recent Adobe news as of July 2026. Adobe is best known for its creative and digital experience software, but its role in AI has been growing across products and services. Joining the Open Source AI Cybersecurity...
NYSE:NOC
NYSE:NOCAerospace & Defense

Northrop Grumman (NOC) Stock Looks Undervalued Despite 62% Gains And Budget Risk

Northrop Grumman stock has delivered a 62.4% gain over the past five years, yet current valuation checks and intrinsic value estimates both point to the shares trading below what the underlying cash flows imply. With market sentiment still digesting mixed shorter term returns, the question is whether the current price fully reflects the company’s long term contract and earnings profile. Over five years, Northrop Grumman has returned 62.4%, which suggests long term holders have been rewarded...
NasdaqGS:ADP
NasdaqGS:ADPProfessional Services

ADP Stock And 2 HR Software Picks For Rising Compliance Demand

Investors watching the latest Goldman Sachs tribunal decision on sex discrimination and unfair dismissal can see how quickly employment disputes turn into real financial and reputational costs. Human resources and employment law services sit close to this pressure point, from compliance advice to managing workplace disputes. When a £1.45mn award and critical findings on dismissal processes hit headlines, that can influence how companies think about risk management and where they spend on...